De-identification and pseudo-anonymization are two commonly used techniques for protecting personal information in real world evidence (RWE) studies.
De-identification involves removing or obscuring any personal identifiers, such as names, addresses, and social security numbers, from a dataset. The goal is to make it impossible to identify individuals in the dataset. However, de-identified data can still potentially be re-identified if combined with other data sources or through statistical analysis.
Pseudo-anonymization involves replacing personal identifiers with a unique identifier, or code, that cannot be traced back to the individual without access to a separate database. This technique provides an additional layer of protection as the original personal identifiers are not included in the dataset. However, there is still a risk that individuals can be re-identified if the codes are compromised or if the separate database is breached.
In the context of RWE, both de-identification and pseudo-anonymization can be effective in protecting personal information. The choice of technique will depend on the level of risk associated with re-identification and the specific requirements of the study. For example, if the dataset contains sensitive information or the risk of re-identification is high, pseudo-anonymization may be preferred. If the risk of re-identification is low and the dataset does not contain sensitive information, de-identification may be sufficient.
It is important to note that neither de-identification nor pseudo-anonymization can guarantee complete protection of personal information. Additional measures, such as access controls and data use agreements, may be necessary to further reduce the risk of re-identification and protect the privacy of individuals in RWE studies.
Share this story...
Real World Evidence (RWE) 101 – Parkinson’s Disease
RWE 101 - Parkinson’s Disease Real-world evidence (RWE) refers to clinical evidence regarding the usage and potential benefits or risks of a treatment derived from analysis of real-world data [...]
Real World Evidence (RWE) 101 – Benefits of RWE in the Context of Rare Diseases
RWE 101 - Benefits of RWE in the Context of Rare Diseases Real-world evidence (RWE) refers to information on health care that comes from real-world settings, such as electronic [...]
Real World Evidence (RWE) 101 – Disease Prevalence vs Incidence
RWE 101 - Disease Prevalence vs Incidence Real-world evidence (RWE), derived from real-world data (RWD), allows us to gain insights into disease prevalence and incidence outside of controlled clinical [...]
Real World Evidence (RWE) 101 – Principles for Ensuring that Research Results are Reliable, Valid, and Objective
RWE 101 - Principles for Ensuring that Research Results are Reliable, Valid, and Objective Ensuring that research results are reliable, valid, and objective requires careful planning, execution, and evaluation. [...]
Real World Evidence (RWE) 101 – Why Should Non-Interventional Studies NOT be Promotional?
RWE 101 - Why Should Non-Interventional Studies NOT be Promotional? Non-interventional studies (NIS) are designed to observe and analyze data from real-world clinical settings without intervening or manipulating any [...]
Real World Evidence (RWE) 101 – Seeding Studies
RWE 101 - Seeding Studies Seeding studies, in the context of real-world evidence (RWE), refer to studies that were conducted by pharmaceutical or medical device companies after a product's [...]







